Global and China Inhalation Powder Budesonide Market Insights, Forecast to 2027
Table of Contents1 Study Coverage
1.1 Inhalation Powder Budesonide Product Introduction
1.2 Market by Type
1.2.1 Global Inhalation Powder Budesonide Market Size Growth Rate by Type
1.2.2 100~200 Inhalation
1.2.3 Other
1.3 Market by Application
1.3.1 Global Inhalation Powder Budesonide Market Size Growth Rate by Application
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhalation Powder Budesonide Market Size, Estimates and Forecasts
2.1.1 Global Inhalation Powder Budesonide Revenue 2016-2027
2.1.2 Global Inhalation Powder Budesonide Sales 2016-2027
2.2 Global Inhalation Powder Budesonide, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Inhalation Powder Budesonide Historical Market Size by Region (2016-2021)
2.3.1 Global Inhalation Powder Budesonide Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Inhalation Powder Budesonide Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Inhalation Powder Budesonide Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Inhalation Powder Budesonide Sales Forecast by Region (2022-2027)
2.4.2 Global Inhalation Powder Budesonide Revenue Forecast by Region (2022-2027)
3 Global Inhalation Powder Budesonide Competitor Landscape by Players
3.1 Global Top Inhalation Powder Budesonide Manufacturers by Sales
3.1.1 Global Inhalation Powder Budesonide Sales by Manufacturer (2016-2021)
3.1.2 Global Inhalation Powder Budesonide Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Inhalation Powder Budesonide Manufacturers by Revenue
3.2.1 Key Inhalation Powder Budesonide Manufacturers Covered: Ranking by Revenue
3.2.2 Global Inhalation Powder Budesonide Revenue by Manufacturers (2016-2021)
3.2.3 Global Inhalation Powder Budesonide Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Inhalation Powder Budesonide Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Inhalation Powder Budesonide Revenue in 2020
3.2.6 Global Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Inhalation Powder Budesonide Price by Manufacturers
3.4 Global Inhalation Powder Budesonide Manufacturing Base Distribution, Product Types
3.4.1 Inhalation Powder Budesonide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Inhalation Powder Budesonide Product Type
3.4.3 Date of International Manufacturers Enter into Inhalation Powder Budesonide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Inhalation Powder Budesonide Market Size by Type (2016-2021)
4.1.1 Global Inhalation Powder Budesonide Sales by Type (2016-2021)
4.1.2 Global Inhalation Powder Budesonide Revenue by Type (2016-2021)
4.1.3 Inhalation Powder Budesonide Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Inhalation Powder Budesonide Market Size Forecast by Type (2022-2027)
4.2.1 Global Inhalation Powder Budesonide Sales Forecast by Type (2022-2027)
4.2.2 Global Inhalation Powder Budesonide Revenue Forecast by Type (2022-2027)
4.2.3 Inhalation Powder Budesonide Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Inhalation Powder Budesonide Market Size by Application (2016-2021)
5.1.1 Global Inhalation Powder Budesonide Sales by Application (2016-2021)
5.1.2 Global Inhalation Powder Budesonide Revenue by Application (2016-2021)
5.1.3 Inhalation Powder Budesonide Price by Application (2016-2021)
5.2 Inhalation Powder Budesonide Market Size Forecast by Application (2022-2027)
5.2.1 Global Inhalation Powder Budesonide Sales Forecast by Application (2022-2027)
5.2.2 Global Inhalation Powder Budesonide Revenue Forecast by Application (2022-2027)
5.2.3 Global Inhalation Powder Budesonide Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Inhalation Powder Budesonide Market Size YoY Growth 2016-2027
6.1.1 China Inhalation Powder Budesonide Sales YoY Growth 2016-2027
6.1.2 China Inhalation Powder Budesonide Revenue YoY Growth 2016-2027
6.1.3 China Inhalation Powder Budesonide Market Share in Global Market 2016-2027
6.2 China Inhalation Powder Budesonide Market Size by Players (International and Local Players)
6.2.1 China Top Inhalation Powder Budesonide Players by Sales (2016-2021)
6.2.2 China Top Inhalation Powder Budesonide Players by Revenue (2016-2021)
6.3 China Inhalation Powder Budesonide Historic Market Review by Type (2016-2021)
6.3.1 China Inhalation Powder Budesonide Sales Market Share by Type (2016-2021)
6.3.2 China Inhalation Powder Budesonide Revenue Market Share by Type (2016-2021)
6.3.3 China Inhalation Powder Budesonide Price by Type (2016-2021)
6.4 China Inhalation Powder Budesonide Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Inhalation Powder Budesonide Sales Forecast by Type (2022-2027)
6.4.2 China Inhalation Powder Budesonide Revenue Forecast by Type (2022-2027)
6.4.3 China Inhalation Powder Budesonide Price Forecast by Type (2022-2027)
6.5 China Inhalation Powder Budesonide Historic Market Review by Application (2016-2021)
6.5.1 China Inhalation Powder Budesonide Sales Market Share by Application (2016-2021)
6.5.2 China Inhalation Powder Budesonide Revenue Market Share by Application (2016-2021)
6.5.3 China Inhalation Powder Budesonide Price by Application (2016-2021)
6.6 China Inhalation Powder Budesonide Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Inhalation Powder Budesonide Sales Forecast by Application (2022-2027)
6.6.2 China Inhalation Powder Budesonide Revenue Forecast by Application (2022-2027)
6.6.3 China Inhalation Powder Budesonide Price Forecast by Application (2022-2027)
7 North America
7.1 North America Inhalation Powder Budesonide Market Size YoY Growth 2016-2027
7.2 North America Inhalation Powder Budesonide Market Facts & Figures by Country
7.2.1 North America Inhalation Powder Budesonide Sales by Country (2016-2021)
7.2.2 North America Inhalation Powder Budesonide Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Inhalation Powder Budesonide Market Size YoY Growth 2016-2027
8.2 Asia Pacific Inhalation Powder Budesonide Market Facts & Figures by Region
8.2.1 Asia Pacific Inhalation Powder Budesonide Sales by Region (2016-2021)
8.2.2 Asia Pacific Inhalation Powder Budesonide Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Inhalation Powder Budesonide Market Size YoY Growth 2016-2027
9.2 Europe Inhalation Powder Budesonide Market Facts & Figures by Country
9.2.1 Europe Inhalation Powder Budesonide Sales by Country (2016-2021)
9.2.2 Europe Inhalation Powder Budesonide Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Inhalation Powder Budesonide Market Size YoY Growth 2016-2027
10.2 Latin America Inhalation Powder Budesonide Market Facts & Figures by Country
10.2.1 Latin America Inhalation Powder Budesonide Sales by Country (2016-2021)
10.2.2 Latin America Inhalation Powder Budesonide Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Inhalation Powder Budesonide Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Inhalation Powder Budesonide Market Facts & Figures by Country
11.2.1 Middle East and Africa Inhalation Powder Budesonide Sales by Country (2016-2021)
11.2.2 Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Inhalation Powder Budesonide Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Inhalation Powder Budesonide Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Inhalation Powder Budesonide Products Offered
12.3.5 Mylan Recent Development
12.4 Sandoz
12.4.1 Sandoz Corporation Information
12.4.2 Sandoz Description and Business Overview
12.4.3 Sandoz Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sandoz Inhalation Powder Budesonide Products Offered
12.4.5 Sandoz Recent Development
12.5 Cosmo Pharmaceuticals
12.5.1 Cosmo Pharmaceuticals Corporation Information
12.5.2 Cosmo Pharmaceuticals Description and Business Overview
12.5.3 Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cosmo Pharmaceuticals Inhalation Powder Budesonide Products Offered
12.5.5 Cosmo Pharmaceuticals Recent Development
12.6 Salix
12.6.1 Salix Corporation Information
12.6.2 Salix Description and Business Overview
12.6.3 Salix Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Salix Inhalation Powder Budesonide Products Offered
12.6.5 Salix Recent Development
12.7 Chiesi Farmaceutici
12.7.1 Chiesi Farmaceutici Corporation Information
12.7.2 Chiesi Farmaceutici Description and Business Overview
12.7.3 Chiesi Farmaceutici Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chiesi Farmaceutici Inhalation Powder Budesonide Products Offered
12.7.5 Chiesi Farmaceutici Recent Development
12.8 Orion Corporation
12.8.1 Orion Corporation Corporation Information
12.8.2 Orion Corporation Description and Business Overview
12.8.3 Orion Corporation Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Orion Corporation Inhalation Powder Budesonide Products Offered
12.8.5 Orion Corporation Recent Development
12.9 Cipla
12.9.1 Cipla Corporation Information
12.9.2 Cipla Description and Business Overview
12.9.3 Cipla Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Cipla Inhalation Powder Budesonide Products Offered
12.9.5 Cipla Recent Development
12.10 Synmosa Biopharma
12.10.1 Synmosa Biopharma Corporation Information
12.10.2 Synmosa Biopharma Description and Business Overview
12.10.3 Synmosa Biopharma Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Synmosa Biopharma Inhalation Powder Budesonide Products Offered
12.10.5 Synmosa Biopharma Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Inhalation Powder Budesonide Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Shanghai Sine Promod
12.12.1 Shanghai Sine Promod Corporation Information
12.12.2 Shanghai Sine Promod Description and Business Overview
12.12.3 Shanghai Sine Promod Inhalation Powder Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shanghai Sine Promod Products Offered
12.12.5 Shanghai Sine Promod Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Inhalation Powder Budesonide Industry Trends
13.2 Inhalation Powder Budesonide Market Drivers
13.3 Inhalation Powder Budesonide Market Challenges
13.4 Inhalation Powder Budesonide Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Inhalation Powder Budesonide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Global Inhalation Powder Budesonide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 100~200 Inhalation
Table 3. Major Manufacturers of Other
Table 4. Global Inhalation Powder Budesonide Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Inhalation Powder Budesonide Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Inhalation Powder Budesonide Sales by Regions (2016-2021) & (K Units)
Table 7. Global Inhalation Powder Budesonide Sales Market Share by Regions (2016-2021)
Table 8. Global Inhalation Powder Budesonide Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Inhalation Powder Budesonide Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Inhalation Powder Budesonide Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Inhalation Powder Budesonide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Inhalation Powder Budesonide Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Inhalation Powder Budesonide Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Inhalation Powder Budesonide Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Inhalation Powder Budesonide Manufacturers by Revenue (US$ Million) in 2020
Table 16. Inhalation Powder Budesonide Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Inhalation Powder Budesonide Revenue Share by Manufacturers (2016-2021)
Table 18. Global Inhalation Powder Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Inhalation Powder Budesonide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalation Powder Budesonide as of 2020)
Table 20. Key Manufacturers Inhalation Powder Budesonide Price (2016-2021) (US$/Unit)
Table 21. Inhalation Powder Budesonide Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Inhalation Powder Budesonide Product Type
Table 23. Date of International Manufacturers Enter into Inhalation Powder Budesonide Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Inhalation Powder Budesonide Sales by Type (2016-2021) (K Units)
Table 26. Global Inhalation Powder Budesonide Sales Share by Type (2016-2021)
Table 27. Global Inhalation Powder Budesonide Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Inhalation Powder Budesonide Revenue Share by Type (2016-2021)
Table 29. Inhalation Powder Budesonide Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Inhalation Powder Budesonide Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Inhalation Powder Budesonide Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Inhalation Powder Budesonide Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Inhalation Powder Budesonide Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Inhalation Powder Budesonide Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Inhalation Powder Budesonide Sales by Application (2016-2021) (K Units)
Table 36. Global Inhalation Powder Budesonide Sales Share by Application (2016-2021)
Table 37. Global Inhalation Powder Budesonide Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Inhalation Powder Budesonide Revenue Share by Application (2016-2021)
Table 39. Inhalation Powder Budesonide Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Inhalation Powder Budesonide Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Inhalation Powder Budesonide Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Inhalation Powder Budesonide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Inhalation Powder Budesonide Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Inhalation Powder Budesonide Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Inhalation Powder Budesonide Sales (K Units) of Key Companies (2016-2021)
Table 46. China Inhalation Powder Budesonide Sales Share by Company (2016-2021)
Table 47. China Inhalation Powder Budesonide Revenue (US$ Million) by Company (2016-2021)
Table 48. China Inhalation Powder Budesonide Revenue Share by Company (2016-2021)
Table 49. China Inhalation Powder Budesonide Sales (K Units) by Type (2016-2021)
Table 50. China Inhalation Powder Budesonide Sales Share by Type (2016-2021)
Table 51. China Inhalation Powder Budesonide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Inhalation Powder Budesonide Price (US$/Unit) by Type (2016-2021)
Table 53. China Inhalation Powder Budesonide Sales (K Units) by Type (2022-2027)
Table 54. China Inhalation Powder Budesonide Sales Share by Type (2022-2027)
Table 55. China Inhalation Powder Budesonide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Inhalation Powder Budesonide Revenue Share by Type (2022-2027)
Table 57. China Inhalation Powder Budesonide Price (US$/Unit) by Type (2022-2027)
Table 58. China Inhalation Powder Budesonide Sales (K Units) by Application (2016-2021)
Table 59. China Inhalation Powder Budesonide Sales Share by Application (2016-2021)
Table 60. China Inhalation Powder Budesonide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Inhalation Powder Budesonide Price (US$/Unit) by Application (2016-2021)
Table 62. China Inhalation Powder Budesonide Sales (K Units) by Application (2022-2027)
Table 63. China Inhalation Powder Budesonide Sales Share by Application (2022-2027)
Table 64. China Inhalation Powder Budesonide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Inhalation Powder Budesonide Revenue Share by Application (2022-2027)
Table 66. China Inhalation Powder Budesonide Price (US$/Unit) by Application (2022-2027)
Table 67. North America Inhalation Powder Budesonide Sales by Country (2016-2021) & (K Units)
Table 68. North America Inhalation Powder Budesonide Sales Market Share by Country (2016-2021)
Table 69. North America Inhalation Powder Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Inhalation Powder Budesonide Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Inhalation Powder Budesonide Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Inhalation Powder Budesonide Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Inhalation Powder Budesonide Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Inhalation Powder Budesonide Revenue Market Share by Region (2016-2021)
Table 75. Europe Inhalation Powder Budesonide Sales by Country (2016-2021) & (K Units)
Table 76. Europe Inhalation Powder Budesonide Sales Market Share by Country (2016-2021)
Table 77. Europe Inhalation Powder Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Inhalation Powder Budesonide Revenue Market Share by Country (2016-2021)
Table 79. Latin America Inhalation Powder Budesonide Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Inhalation Powder Budesonide Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Inhalation Powder Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Inhalation Powder Budesonide Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Inhalation Powder Budesonide Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Inhalation Powder Budesonide Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Inhalation Powder Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Inhalation Powder Budesonide Revenue Market Share by Country (2016-2021)
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. AstraZeneca Inhalation Powder Budesonide Product
Table 91. AstraZeneca Recent Development
Table 92. Teva Corporation Information
Table 93. Teva Description and Business Overview
Table 94. Teva Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Teva Product
Table 96. Teva Recent Development
Table 97. Mylan Corporation Information
Table 98. Mylan Description and Business Overview
Table 99. Mylan Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Mylan Product
Table 101. Mylan Recent Development
Table 102. Sandoz Corporation Information
Table 103. Sandoz Description and Business Overview
Table 104. Sandoz Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Sandoz Product
Table 106. Sandoz Recent Development
Table 107. Cosmo Pharmaceuticals Corporation Information
Table 108. Cosmo Pharmaceuticals Description and Business Overview
Table 109. Cosmo Pharmaceuticals Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Cosmo Pharmaceuticals Product
Table 111. Cosmo Pharmaceuticals Recent Development
Table 112. Salix Corporation Information
Table 113. Salix Description and Business Overview
Table 114. Salix Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Salix Product
Table 116. Salix Recent Development
Table 117. Chiesi Farmaceutici Corporation Information
Table 118. Chiesi Farmaceutici Description and Business Overview
Table 119. Chiesi Farmaceutici Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Chiesi Farmaceutici Product
Table 121. Chiesi Farmaceutici Recent Development
Table 122. Orion Corporation Corporation Information
Table 123. Orion Corporation Description and Business Overview
Table 124. Orion Corporation Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Orion Corporation Product
Table 126. Orion Corporation Recent Development
Table 127. Cipla Corporation Information
Table 128. Cipla Description and Business Overview
Table 129. Cipla Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Cipla Product
Table 131. Cipla Recent Development
Table 132. Synmosa Biopharma Corporation Information
Table 133. Synmosa Biopharma Description and Business Overview
Table 134. Synmosa Biopharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Synmosa Biopharma Product
Table 136. Synmosa Biopharma Recent Development
Table 137. Lunan Better Pharma Corporation Information
Table 138. Lunan Better Pharma Description and Business Overview
Table 139. Lunan Better Pharma Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Lunan Better Pharma Product
Table 141. Lunan Better Pharma Recent Development
Table 142. Shanghai Sine Promod Corporation Information
Table 143. Shanghai Sine Promod Description and Business Overview
Table 144. Shanghai Sine Promod Inhalation Powder Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Shanghai Sine Promod Product
Table 146. Shanghai Sine Promod Recent Development
Table 147. Inhalation Powder Budesonide Market Trends
Table 148. Inhalation Powder Budesonide Market Drivers
Table 149. Inhalation Powder Budesonide Market Challenges
Table 150. Inhalation Powder Budesonide Market Restraints
Table 151. Inhalation Powder Budesonide Customers List
Table 152. Inhalation Powder Budesonide Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of FiguresFigure 1. Inhalation Powder Budesonide Product Picture
Figure 2. Global Inhalation Powder Budesonide Sales Market Share by Type in 2020 & 2027
Figure 3. 100~200 Inhalation Product Picture
Figure 4. Other Product Picture
Figure 5. Global Inhalation Powder Budesonide Sales Market Share by Application in 2020 & 2027
Figure 6. Respiratory Disease Treatment
Figure 7. Nose Disease Treatment
Figure 8. Inflammatory Bowel Disease Treatment
Figure 9. Other
Figure 10. Inhalation Powder Budesonide Report Years Considered
Figure 11. Global Inhalation Powder Budesonide Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Inhalation Powder Budesonide Market Size 2016-2027 (US$ Million)
Figure 13. Global Inhalation Powder Budesonide Sales 2016-2027 (K Units)
Figure 14. Global Inhalation Powder Budesonide Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Inhalation Powder Budesonide Sales Market Share by Region (2016-2021)
Figure 16. Global Inhalation Powder Budesonide Sales Market Share by Region in 2020
Figure 17. Global Inhalation Powder Budesonide Revenue Market Share by Region (2016-2021)
Figure 18. Global Inhalation Powder Budesonide Revenue Market Share by Region in 2020
Figure 19. Global Inhalation Powder Budesonide Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Inhalation Powder Budesonide Revenue in 2020
Figure 21. Inhalation Powder Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Inhalation Powder Budesonide Sales Market Share by Type (2016-2021)
Figure 23. Global Inhalation Powder Budesonide Sales Market Share by Type in 2020
Figure 24. Global Inhalation Powder Budesonide Revenue Market Share by Type (2016-2021)
Figure 25. Global Inhalation Powder Budesonide Revenue Market Share by Type in 2020
Figure 26. Global Inhalation Powder Budesonide Sales Market Share by Application (2016-2021)
Figure 27. Global Inhalation Powder Budesonide Sales Market Share by Application in 2020
Figure 28. Global Inhalation Powder Budesonide Revenue Market Share by Application (2016-2021)
Figure 29. Global Inhalation Powder Budesonide Revenue Market Share by Application in 2020
Figure 30. China Inhalation Powder Budesonide Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Inhalation Powder Budesonide Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Inhalation Powder Budesonide Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Inhalation Powder Budesonide Players Market Share by Revenue in Inhalation Powder Budesonide in 2020
Figure 34. China Inhalation Powder Budesonide Revenue Share by Type (2016-2021)
Figure 35. China Inhalation Powder Budesonide Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Inhalation Powder Budesonide Revenue Share by Application (2016-2021)
Figure 37. China Inhalation Powder Budesonide Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Inhalation Powder Budesonide Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Inhalation Powder Budesonide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Inhalation Powder Budesonide Sales Market Share by Country in 2020
Figure 41. North America Inhalation Powder Budesonide Revenue Market Share by Country in 2020
Figure 42. United States Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 43. United States Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Inhalation Powder Budesonide Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Inhalation Powder Budesonide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Inhalation Powder Budesonide Sales Market Share by Country in 2020
Figure 49. Europe Inhalation Powder Budesonide Revenue Market Share by Country in 2020
Figure 50. Germany Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Inhalation Powder Budesonide Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Inhalation Powder Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Inhalation Powder Budesonide Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Inhalation Powder Budesonide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Inhalation Powder Budesonide Sales Market Share by Region in 2020
Figure 63. Asia Pacific Inhalation Powder Budesonide Revenue Market Share by Region in 20